The company leverages four manufacturing facilities and 41 warehouses to maintain a robust supply chain, with efforts underway to scale production and integrate acquired molecules as of 2026-07-22, including Triadimenol and Iprovalicarb, to drive future growth in both domestic and international markets. The company has reduced debt and is almost debt free, providing financial flexibility for expansion and shareholder returns.
Cyborg Score Rationale
Dhanuka Agritech reported resilient growth for the year ended March 31, 2026, achieving Rs. 483.34 crore in revenue for Q4 FY26 representing a 9% year-on-year growth, with strong operational efficiency and a favorable product mix contributing to a robust Profit After Tax of Rs. 97.77 crore. Financial strength and market positioning are solid, though near-term weather volatility and international expansion challenges present execution risks.
Top Insights
For FY26, Dhanuka Agritech reported a net profit of ₹2,872.35 crore and revenue from operations of ₹20,197.90 crore, reflecting strong profitability conversion and expansion across its portfolio of insecticides, fungicides, and herbicides.
Revenue split in Q2 FY26 shows Insecticides at 46%, Fungicides at 29%, Herbicides at 9%, and Others at 16%, demonstrating diversified exposure across multiple crop protection categories while maintaining pricing discipline.
The board recommended a dividend of 100% (Rs. 2 per equity share) and approved a Rs. 70 crore share buyback program approved in May 2026, signaling confidence in earnings sustainability and commitment to shareholder capital returns.
Named Competitors
Sumitomo Chemical — Global agrochemical and specialty chemical manufacturer
Corteva Agriscience — Global crop protection and seed platform
BASF Agricultural Solutions — Diversified chemical company with major crop protection division
UPL Limited — Indian agrochemical manufacturer and distributor
Recent Developments
(July 2026) Final dividend of ₹2/share proposed; record date July 17, 2026, with AGM scheduled for August 3, 2026
(May 2026) Q4 FY26 results showed 9% YoY revenue growth to ₹483.34 crore with net profit of ₹97.77 crore; board approved ₹70 crore share buyback at ₹1,400 per share
(March 2026) FY26 full-year revenue reached ₹20,197.90 crore with net profit of ₹2,872.35 crore; integrated Bayer-acquired molecules (Triadimenol and Iprovalicarb) in international commercialization
Open the full interactive Dhanuka Agritech Ltd report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.